LASMIDTIME 100 (Lasmiditan 100 mg) – Steris Healthcare

What is LASMIDTIME 100 (Lasmiditan 100 mg) For?

LASMIDTIME 100 is built around Lasmiditan 100 mg, a first-in-class "ditan" molecule specifically developed for acute migraine treatment. Unlike triptans, which act on multiple serotonin receptor subtypes including vascular 5-HT1B receptors, Lasmiditan selectively targets 5-HT1F receptors, avoiding significant vasoconstrictive activity. This makes LASMIDTIME 100 a valuable therapeutic option for migraine patients who have cardiovascular contraindications, coronary artery disease, or a history of stroke — populations where traditional triptan therapy is often avoided. Manufactured under WHO-GMP and ISO 9001:2018 certified conditions by Steris Healthcare, LASMIDTIME 100 delivers reliable potency for rapid symptom control during a migraine attack.

Why It's Important

Migraine is a debilitating neurological condition affecting millions, often accompanied by throbbing head pain, nausea, and sensory sensitivity that can disrupt work and daily life for hours or days. For a significant subset of patients, standard triptan therapy is off-limits due to underlying cardiovascular risk factors, leaving a real treatment gap. LASMIDTIME 100 is important because it fills this gap with a vascular-neutral mechanism, giving physicians a genuine acute-care option for patients who previously had limited effective choices during a migraine episode.

Key Benefits of Lasmiditan 100 mg

What Are the Benefits?

  • Provides effective acute relief from migraine pain and associated symptoms
  • Works through a non-vasoconstrictive mechanism, unlike traditional triptans
  • Suitable option for migraine patients with cardiovascular risk factors or contraindications to triptans
  • Helps reduce migraine-associated nausea, photophobia, and phonophobia
  • Oral tablet formulation allows for convenient, at-home acute dosing
  • Manufactured with strict quality assurance by Steris Healthcare

Mechanism of Action

Lasmiditan works by selectively binding to and activating 5-HT1F serotonin receptors, which are densely expressed in the trigeminal ganglion and trigeminal nucleus caudalis — key structures involved in migraine pain signaling. By activating these receptors, Lasmiditan inhibits the release of pro-inflammatory neuropeptides such as CGRP (calcitonin gene-related peptide) from trigeminal nerve endings, reducing neurogenic inflammation and pain transmission along the trigeminovascular pathway. Because 5-HT1F receptors are largely absent from vascular smooth muscle, this action occurs without the vasoconstrictive effects seen with 5-HT1B-targeting triptans, making it a distinct and cardiovascular-friendly approach to migraine treatment.

Side Effects

Common, generally mild and transient side effects of LASMIDTIME 100 may include:

  • Dizziness
  • Fatigue or drowsiness
  • Paresthesia (tingling sensation)
  • Nausea
  • Sedation

Serious Side Effects Of LASMIDTIME 100

Seek medical attention promptly if you experience:

  • Severe dizziness affecting ability to drive or operate machinery
  • Signs of serotonin syndrome (agitation, rapid heartbeat, high fever, muscle rigidity)
  • Severe allergic reaction (rash, swelling, difficulty breathing)
  • Symptoms of medication overuse headache with frequent use

Available Substitute For LASMIDTIME 100

Patients unable to access LASMIDTIME 100 may be prescribed other Lasmiditan 100 mg brands available in the market, based on their neurologist's advice, since formulation consistency and excipient quality can vary between manufacturers. Any brand substitution should be made under medical supervision, particularly given the drug's CNS depressant effects and driving-related precautions.

Dosage Guidelines For LASMIDTIME 100

PopulationRecommended DoseFrequency
Adults50 mg to 100 mgSingle dose at onset of migraine
MaximumDo not exceed 200 mgPer 24-hour period
Elderly/Hepatic-impaired   As advised by physician   Individualised

Tablets should be taken with or without food, at the first sign of a migraine attack, strictly as directed by a registered medical practitioner. Avoid driving or operating heavy machinery for at least 8 hours after each dose.

Precautions & Warnings

  • Avoid use in patients with known hypersensitivity to Lasmiditan
  • Causes CNS depression; do not drive or operate machinery for at least 8 hours post-dose
  • Avoid alcohol and other CNS depressants while on therapy
  • Use caution when combined with other serotonergic drugs due to serotonin syndrome risk
  • Not recommended for use in pregnancy or breastfeeding unless advised by a physician
  • Limit use to avoid medication overuse headache; do not use for more than the prescribed frequency
  • Keep out of reach of children

Conclusion

LASMIDTIME 100 (Lasmiditan 100 mg) from Steris Healthcare offers a novel, vascular-neutral approach to acute migraine treatment, especially valuable for patients with cardiovascular risk factors that limit triptan use. Backed by WHO-GMP manufacturing standards and a targeted 5-HT1F mechanism, it stands as a dependable option for neurologists seeking effective, differentiated migraine relief for their patients.

Comments

Popular posts from this blog

Steris Healthcare: Committed to Quality Healthcare and Pharmaceutical Excellence

N-Acetyl L-Cysteine (NAC), Pine Bark Extract and Resveratrol Tablets for Daily Wellness